Summary
- Current Price
- As of today, VYNE price is $0.76, down -0.91% on
- Current Price All-Time High
- VYNE price is currently -99.97% below its historical high of $2,869.92 set on
- Market Cap
- VYNE current market cap is $25M, up +7.07% over the past 365 days
- Revenue
- VYNE current annual revenue is $570.00K, up +13.77% year-over-year
- Next Earnings
- As of today, the next earnings release for VYNE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | VYNE Therapeutics Inc. |
| Ticker | NASDAQ: VYNE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vynetherapeutics.com |
| Employees | 13 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.76 | ||
| Price, 1D Change | -0.91% | |
| $25M | ||
| - | ||
| - | ||
| 0.57 | ||
| $570K | ||
| Revenue, 1Y Change | +13.77% | |
| -$0.62 | ||
| EPS, 1Y Change | +33.80% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | $0.38 | |
| Last Split | 1:18 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MNLO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.62 | ||
| EPS Estimate | N/A | -$1.10 |
| EPS Est. Change | N/A | -77.65% |
| $570.00K | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.76 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.94 | - | |
| -$0.89 | -$0.62 | +30.43% | |
| -$1.10 | N/A | -77.65% | |
| -$1.65 | N/A | -166.47% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $550.00K | $501.00K | -8.91% | |
| $600.00K | $570.00K | -5.00% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -36.58% | ||
| -82.67% | ||
| +7.07% | ||
| +76.31% | ||
| +13.77% | ||
| +19.50% | ||
| +33.80% | ||
| +94.54% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.76 | ||
| $0.55 | ||
| $0.67 | ||
| $0.70 | ||
| $0.67 | ||
| $0.02 | ||
| 0.57 | ||
| $0.04 | ||
| 68.99 | ||
| 65.67% | ||
| 105.50% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | $0.38 | |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $570.00K | ||
| -$0.62 | ||
| $547.00K | ||
| 95.96% | ||
| -$29.75M | ||
| -5,219.12% | ||
| -$26.74M | ||
| -4,690.53% | ||
| -$29.73M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 12.53 | ||
| 12.53 | ||
| - | ||
| 1 | ||
| -30.94 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 55.96 | ||
| 1.03 | ||
| -0.02 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $27.76M | ||
| $29.01M | ||
| $30.16M | ||
| $30.01M | ||
| $2.40M | ||
| $2.40M | ||
| $0.00 | ||
| $0.00 | ||
| $1.04M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $27.31M | ||
| $30.30M | ||
| $23.00K | ||
| $11.08M | ||
| $23.00K | ||
| $0.00 | ||
| $4,000.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$33.12M | ||
| $37.37M | ||
| -$143.00K | ||
| $0.00 | ||
| -$33.12M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with VYNE
FAQ
What is the ticker symbol for VYNE Therapeutics Inc.?
The ticker symbol for VYNE Therapeutics Inc. is NASDAQ:VYNE
Does VYNE Therapeutics Inc. pay dividends?
No, VYNE Therapeutics Inc. does not pay dividends
What sector is VYNE Therapeutics Inc. in?
VYNE Therapeutics Inc. is in the Healthcare sector
What industry is VYNE Therapeutics Inc. in?
VYNE Therapeutics Inc. is in the Biotechnology industry
What country is VYNE Therapeutics Inc. based in?
VYNE Therapeutics Inc. is headquartered in United States
When did VYNE Therapeutics Inc. go public?
VYNE Therapeutics Inc. initial public offering (IPO) was on January 25, 2018
Is VYNE Therapeutics Inc. in the S&P 500?
No, VYNE Therapeutics Inc. is not included in the S&P 500 index
Is VYNE Therapeutics Inc. in the NASDAQ 100?
No, VYNE Therapeutics Inc. is not included in the NASDAQ 100 index
Is VYNE Therapeutics Inc. in the Dow Jones?
No, VYNE Therapeutics Inc. is not included in the Dow Jones index
When was VYNE Therapeutics Inc. last earnings report?
VYNE Therapeutics Inc.'s most recent earnings report was on November 7, 2025
When does VYNE Therapeutics Inc. report earnings?
The date for VYNE Therapeutics Inc.'s next earnings report has not been announced yet
Data Sources & References
- VYNE Official Website vynetherapeutics.com
- VYNE Profile on Yahoo Finance finance.yahoo.com/quote/VYNE
- VYNE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vyne